Taking into account all these considerations, in the present study we aimed to determine, for the first time, whether 6 genetic variants at IL33 and IL1RL1, previously associated with immune-mediated diseases, are involved in the risk of subclinical atherosclerosis in Spanish patients with RA. This evidence concerns the gene IL33 and atherosclerosis.